This morning, Advaxis Inc. (NASDAQ:ADXS) held a conference call to provided an update on its pipeline programs and laid out a timeline for multiple milestones …
On Wednesday, Keryx Biopharmaceuticals (NASDAQ:KERX) made the announcement that two major insurance providers added Auryxia, a drug used to control serum phosphorous levels in patients with …
Shares of Celator Pharmaceuticals Inc (NASDAQ:CPXX) closed yesterday up almost 24% after the company reported that CPX-351, a drug aimed to treat Acute Myeloid Leukemia …
MLV analyst Raghuram Selvaraju was out pounding the table on Advaxis, Inc. (NASDAQ:ADXS) Friday, reiterating a Buy rating on the stock with a price target of …
Thomas Yip, equity research analyst at MLV & Co., weighed in today with a favorable report on Threshold Pharmaceuticals, Inc.
In a research report issued today, MLV analyst Thomas Yip maintained a Buy rating on Peregrine Pharma (NASDAQ:PPHM) with a price target of …
In a research note issued today, MLV analyst Arlinda Lee reiterated a Buy rating on Halozyme Therapeutics, Inc. (NASDAQ:HALO) with a price target of $20, following the …
MLV’s healthcare analyst Thomas Yip weighed in today with a few insights on OXiGENE Inc (NASDAQ:OXGN), after the company announced the basic design of an upcoming …
In a research report issued today, MLV analyst Thomas Yip reiterated a Buy rating on Peregrine Pharmaceuticals (NASDAQ:PPHM) with a $3.50 price target, after …
MLV analyst Christopher Nolan came out again today with a research report on Prospect Capital Corporation (NASDAQ:PSEC), decreasing the price target to $9.00 (from $10.
